Kapadia SR, Leon MB, Makkar RR, Tuzcu EM, Svensson LG, Kodali S, et al. 5-year outcomes of transcatheter aortic valve replacement compared with standard treatment for patients with inoperable aortic stenosis (PARTNER 1): A randomised controlled trial. Lancet. 2015;385:2485–91. https://doi.org/10.1016/S0140-6736(15)60290-2.
Mack MJ, Leon MB, Smith CR, Miller DC, Moses JW, Tuzcu EM, et al. 5-year outcomes of transcatheter aortic valve replacement or surgical aortic valve replacement for high surgical risk patients with aortic stenosis (PARTNER 1): A randomized controlled trial. Lancet. 2015;385:2477–84. https://doi.org/10.1016/S0140-6736(15)60308-7.
Mack MJ, Leon MB, Thourani VH, Makkar R, Kodali SK, Russo M, et al. Transcatheter aortic valve replacement with balloon-expandable valve in low-risk patients. N Engl J Med. 2019;380:1695–705. https://doi.org/10.1056/NEJMoa1814052.
Makkar RR, Thourani VH, Mack MJ, Kodali SK, Kapadia S, Webb JG, et al. Five-year outcomes of transcatheter and surgical aortic valve replacement. N Engl J Med. 2020;382:799–809. https://doi.org/10.1056/NEJMoa1910555.
Thyregod HGH, Jørgensen TH, Ihlemann N, Steinbrüchel DA, Nissen H, Kjeldsen BJ, et al. Transcatheter or surgical aortic valve implantation: The 10-year outcomes of the NOTION trial. Eur Heart J. 2024;45:1116–24. https://doi.org/10.1093/eurheartj/ehae043.
Article PubMed PubMed Central Google Scholar
Otto CM, Nishimura RA, Bonow RO, Carabello BA, Erwin JP 3rd, Gentile F, et al. 2020 ACC/AHA guideline for the management of patients with valvular heart disease: Executive summary: A report of the American College of Cardiology/American Heart Association joint committee on clinical practice guidelines. Circulation. 2020;143:e35–71. https://doi.org/10.1161/CIR.0000000000000932.
Praz F, Borger MA, Lanz J, Marin-Cuartas M, Abreu A, Adamo M, et al. 2025 ESC/EACTS Guidelines for the management of valvular heart disease. Eur Heart J. 2025;46:4635–736. https://doi.org/10.1093/eurheartj/ehaf194.
Article CAS PubMed Google Scholar
Mauri V, Abdel-Wahab M, Bleiziffer S, Veulemans V, Sedaghat A, Adam M, et al. Temporal trends of TAVI treatment characteristics in high volume centers in Germany 2013–2020. Clin Res Cardiol. 2022;111:881–8. https://doi.org/10.1007/s00392-021-01963-3.
VARC-3 WRITING COMMITTEE, Généreux P, Piazza N, Alu MC, Nazif T, Hahn RT, et al. Valve Academic Research Consortium 3: Updated endpoint definitions for aortic valve clinical research. Eur Heart J. 2021;42:1825–57. https://doi.org/10.1093/eurheartj/ehaa799.
Wassef AWA, Rodes-Cabau J, Liu Y, Webb JG, Barbanti M, Munoz-Garcia AJ, et al. The Learning Curve and Annual Procedure Volume Standards for Optimum Outcomes of Transcatheter Aortic Valve Replacement: Findings From an International Registry. JACC Cardiovasc Interv. 2018;11:1669–79. https://doi.org/10.1016/j.jcin.2018.06.044.
Nakamura M, Kimura K, Kimura T, Ishihara M, Otsuka F, Kozuma K, et al. JCS 2020 guideline focused update on antithrombotic therapy in patients with coronary artery disease. Circ J. 2020;84:831–65. https://doi.org/10.1253/circj.CJ-19-1109.
Martínez-Sellés M. Geriatric management and TAVI: Time to change from Heart Team to Patient Team. Eur Geriatr Med. 2024;15:1631–3. https://doi.org/10.1007/s41999-024-01061-3.
Iwata J, Hayashida K, Kajino A, Sakata S, Imaeda S, Ryuzaki T, et al. Clinical outcomes, hemodynamics, and leaflet thrombosis following transcatheter aortic valve replacement with novel intra-annular devices. Health Sci Rep. 2025;8:e70097. https://doi.org/10.1002/hsr2.70097.
Article PubMed PubMed Central Google Scholar
Fiore M, Tonchev AB, Pancheva RZ, Yamashima T, Venditti S, Ferraguti G, et al. Increasing life expectancy with plant polyphenols: Lessons from the Mediterranean and Japanese diets. Molecules. 2025;30:2888. https://doi.org/10.3390/molecules30132888.
Article CAS PubMed PubMed Central Google Scholar
Watanabe Y, Hayashida K, Takayama M, Mitsudo K, Nanto S, Takanashi S, et al. First direct comparison of clinical outcomes between European and Asian cohorts in transcatheter aortic valve implantation: The Massy study group vs. the PREVAIL Japan trial. J Cardiol. 2015;65:112–6. https://doi.org/10.1016/j.jjcc.2014.05.001.
Inohara T, Hayashida K, Watanabe Y, Yamamoto M, Takagi K, Yashima F, et al. Streamlining the learning process for TAVI: Insight from a comparative analysis of the OCEAN-TAVI and the massy registries. Catheter Cardiovasc Interv. 2016;87:963–70. https://doi.org/10.1002/ccd.26266.
Ochiai T, Oakley L, Sekhon N, Komatsu I, Flint N, Kaewkes D, et al. Risk of coronary obstruction due to sinus sequestration in redo transcatheter aortic valve replacement. JACC Cardiovasc Interv. 2020;13:2617–27. https://doi.org/10.1016/j.jcin.2020.09.022.
Tchétché D, Siddiqui S. TAV-in-TAV for failed prosthesis: The new frontier. EuroIntervention. 2020;16:e100–2. https://doi.org/10.4244/EIJV16I2A15.
Tang GHL, Zaid S, Gupta E, Ahmad H, Khan A, Kovacic JC, et al. Feasibility of repeat TAVR after SAPIEN 3 TAVR: A novel classification scheme and pilot angiographic study. JACC Cardiovasc Interv. 2019;12:1290–2. https://doi.org/10.1016/j.jcin.2019.02.020.
Sá MP, Jacquemyn X, Van den Eynde J, Tasoudis P, Erten O, Sicouri S, et al. Impact of paravalvular Leak on outcomes after transcatheter aortic valve implantation: Meta-analysis of Kaplan-Meier-derived individual patient data. Struct Heart. 2023;7:100118. https://doi.org/10.1016/j.shj.2022.100118.
Watanabe Y, Yamamoto M, Hioki H, Saito M, Omiya J, Kito K, et al. Long-term impact of mild paravalvular regurgitation after transcatheter aortic valve replacement: The OCEAN-TAVI registry. JACC Cardiovasc Interv. 2025;S1936–87982502343–X. https://doi.org/10.1016/j.jcin.2025.09.004.
Deharo P, Leroux L, Theron A, Ferrara J, Vaillier A, Jaussaud N, et al. Long-Term Prognosis Value of paravalvular Leak and Patient-Prosthesis Mismatch following transcatheter Aortic Valve Implantation: Insight from the France-TAVI Registry. J Clin Med. 2022;11:6117. https://doi.org/10.3390/jcm11206117.
Article PubMed PubMed Central Google Scholar
Yamamoto M, Yashima F, Shirai S, Tada N, Naganuma T, Yamawaki M, et al. Performance and outcomes of the SAPIEN 3 Ultra RESILIA transcatheter heart valve in the OCEAN-TAVI registry. EuroIntervention. 2024;20:579–90. https://doi.org/10.4244/EIJ-D-23-00996.
Article PubMed PubMed Central Google Scholar
Husain A, Jelisejevas J, Millar K, Alnuwakhtha A, Ferkh A, Delarive J, et al. Routine post-dilatation at nominal volume to optimise the expansion of balloon-expandable valves: The DOUBLE-TAP study. EuroIntervention. 2025;21:e1159–68. https://doi.org/10.4244/EIJ-D-25-00258.
Comments (0)